Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) registered a jump of 652.65% in net profit to SAR 184.40 million in 2025 from SAR 24.50 million in 2024, according to the income statements.
The earnings per share (EPS) rose to SAR 1.54 in 2025, compared with SAR 0.21 in 2024.
SPIMACO generated 1.47% higher revenue at SAR 1.70 billion in January-December 2025 when compared to SAR 1.68 billion in 2024.
Managing Director and Vice Chairman of SPIMACO, Ahmed Aljedai, said: “Throughout the year [2025], we remained focused on enhancing the quality of our revenue, optimizing our product portfolio, and improving operational efficiency, which supported stronger profitability and reinforced our market leadership in th Kingdom.”
Cash Dividends
The board members of SPIMACO recommended, in their 30 March 2026 meeting, cash dividends' distribution for 2025.
Upon necessary approvals, the company will pay out SAR 0.35 per share, representing 3.50% of the share’s par value, for 120 million eligible shares.
The total amount proposed for distribution stands at SAR 42 million, while the eligibility and payment dates will be announced at a later time.
It is worth noting that in the first nine months (9M) of 2025, SPIMACO posted net profits of SAR 154.70 million and revenue of SAR 1.30 billion.
